3The Sanguis Study Group. Use of blood products for elective surgery in 43 European hospital[J]. Transfus Med, 1994,4(4) : 247-249.
4Eagleton H, Binjamin S, Murphy MF. Audits of appropriate use of FFP[J]. Bloods Matters, 2000,4:5-8.
5高峰.血液制品[M]//高峰主译.临床用血.北京:人民卫生出版社,2002,50-58.
6Scgal J, Dzik WH. Transfusion Medicine/Hcraostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures : an evidence-based review [ J ]. Transfusion, 2005,45 (9) :14131-425.
7Eekman MH, Erban JK, Singh SK, et al. Screening for the risk for bleeding or thrombosis[J]. Ann Intern Med, 2003,138(3) : 15-24.
8Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities [ J ]. Transfusion, 2006,46 (8) :1279-1285.
9Ciavarella D, Reed RL, Counts RB, et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patlent [ J ]. Br J Haematol, 1987,67 ( 3 ) :365-368.
10Murphy MF, Wallington TB, Kelsey P,et al. Guidelines for the clinical use of red cell transfusions[ J]. Bri J Haematol, 2001, 113(1) :24-31.
